What is the appropriate treatment for supraventricular tachycardia?

Treatment of Supraventricular Tachycardia

Begin with vagal maneuvers immediately, followed by adenosine if unsuccessful, and proceed to synchronized cardioversion for hemodynamically unstable patients or when pharmacological therapy fails.

Acute Treatment Algorithm

Hemodynamically Unstable Patients

Perform immediate synchronized cardioversion if the patient presents with hypotension, acutely altered mental status, signs of shock, chest pain, or acute heart failure symptoms 1. However, if the tachycardia is regular with a narrow QRS complex, consider adenosine first before cardioversion 1.

• Synchronized cardioversion is highly effective in terminating SVT and should be considered early to avoid complications from antiarrhythmic drugs 1
• Have electrical cardioversion equipment available whenever administering adenosine, as it may precipitate atrial fibrillation with rapid ventricular conduction or even ventricular fibrillation 1

Hemodynamically Stable Patients

First-Line: Vagal Maneuvers

Perform vagal maneuvers as the initial intervention with the patient in the supine position 1:

• Valsalva maneuver: Patient bears down against a closed glottis for 10-30 seconds, generating at least 30-40 mm Hg intrathoracic pressure 1
• Carotid sinus massage: After confirming absence of bruit by auscultation, apply steady pressure over the right or left carotid sinus for 5-10 seconds 1
• Ice-cold towel to face: Apply an ice-cold, wet towel to the face based on the diving reflex 1
• Switching between Valsalva and carotid massage achieves an overall success rate of 27.7% 1
• Never apply pressure to the eyeball - this is potentially dangerous and has been abandoned 1

Second-Line: Adenosine

Administer adenosine if vagal maneuvers fail 1, 2:

• Adenosine terminates AVNRT in approximately 95% of patients and orthodromic AVRT in 90-95% of patients 1
• Side effects are minor and brief (<1 minute), occurring in approximately 30% of patients 1
• Critical caveat: Adenosine may precipitate atrial fibrillation that can conduct rapidly to the ventricles, potentially causing ventricular fibrillation 1
• Recent evidence from unstable patients shows adenosine may be attempted safely before electrical cardioversion, potentially reducing sedation-related risks 3

Third-Line: Intravenous AV Nodal Blockers

If adenosine fails or is contraindicated, use intravenous calcium channel blockers or beta-blockers 1:

• Diltiazem or verapamil: Terminate SVT in 64-98% of patients 1

  • More effective than beta-blockers for acute termination 1
  • Administer slowly over up to 20 minutes to minimize hypotension 1
  • Do not use if VT or pre-excited atrial fibrillation is suspected, as these may cause hemodynamic instability or ventricular fibrillation 1
  • Avoid in systolic heart failure 1

• Intravenous beta-blockers: Reasonable alternative with excellent safety profile 1

  • Less effective than diltiazem in head-to-head comparison 1

Fourth-Line: Synchronized Cardioversion

Proceed to synchronized cardioversion when pharmacological therapy is ineffective or contraindicated 1:

• Success rates of 80-98% for pharmacological agents mean rare instances require cardioversion 1
• Perform after adequate sedation or anesthesia in stable patients 1
• Consider a second drug bolus or higher dose before resorting to cardioversion 1

Special Considerations

Pre-Excited Atrial Fibrillation (Wide-Complex Irregular Tachycardia)

Immediately perform synchronized cardioversion if hemodynamically unstable 1:

• Rapid pre-excited AV conduction can lead to ventricular fibrillation 1
• Early restoration of sinus rhythm is critical 1

For hemodynamically stable pre-excited AF, use ibutilide or intravenous procainamide 1:

• Both medications slow conduction over the accessory pathway and may terminate AF 1
• Never use AV nodal blockers (diltiazem, verapamil, beta-blockers) in pre-excited AF, as they may enhance accessory pathway conduction and accelerate ventricular rate 1

Focal Atrial Tachycardia

Use intravenous beta-blockers, diltiazem, or verapamil for hemodynamically stable focal AT 4:

• These agents terminate or slow ventricular rate in approximately 30-50% of patients 4
• Monitor closely for hypotension or bradycardia 4

Ongoing Management

For patients with recurrent symptomatic SVT who prefer not to undergo catheter ablation, use oral beta-blockers, diltiazem, or verapamil 1, 2:

• These medications are effective for ongoing management in patients without ventricular pre-excitation 1, 2
• Catheter ablation should be offered as first-line definitive treatment during comprehensive discussion of risks and benefits, given its high success rates and low complication rates 5, 6

Critical Pitfalls to Avoid

1. Never use AV nodal blockers in wide-complex tachycardia until VT and pre-excited AF are definitively excluded 1
2. Avoid calcium channel blockers in systolic heart failure 1
3. Do not use digoxin, amiodarone, or sotalol for acute SVT management - these have been downgraded or removed from current guidelines 5
4. Always have cardioversion equipment immediately available when administering adenosine 1
5. Confirm absence of carotid bruit before performing carotid massage 1